Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Axactor SE - Sale of subscription rights by primary insiders in the subsequent offering

Oslo, 18 February 2021 Reference is made to the stock exchange announcements from Axactor SE(“Axactor” or the "Company") on 9 December 2020 regarding a number of measuresto strengthen the financial platform of the Company, including (i) a privateplacement raising gross proceeds of NOK 320 million (the "Private Placement"),(ii) a potential subsequent offering of up to 26,750,000 new shares at asubscription price of NOK 8.00 per offer share (the “Subsequent Offering”) and(iii) the acquisition of the 50% interest in Axactor Invest held by Geveran withconsideration consisting

CORRECTION to Finnair Plc’s Stock Exchange Release on Shareholders’ Nomination Board’s proposals to Annual General Meeting published on 26 January 2021

Finnair Plc         Stock Exchange Release           18 February 2021 at 5.45 p.m. EET  Finnair Plc corrects the stock exchange release on Shareholders’ Nomination Board’s proposals to Annual General Meeting published on 26 January 2021 at 9.00 a.m. EET. In the original stock exchange release, the company published incorrect Shareholders’ Nomination Board’s proposals to the AGM as it was stated in the release that the annual remunerations of the members of the Board of Directors would remain unchanged, and be the following: · Chairperson 52,020 euros · Vice Chairperson 27,540

Admission to trading

18 February 2021   ENQUEST PLC(the "Company") £6,443,198 7.00 per cent. Extendable PIK Toggle Notes due 15 October 2023 (the "Additional Notes") (consolidated and forming a single series with the existing £184,091,375 (subject to rounding in accordance with the Conditions) 7.00 per cent. Extendable PIK Toggle Notes originally due 15 February 2022, as extended to 15 October 2023 (ISIN: XS0880578728)) On 18 February 2021, the Additional Notes were admitted to the Official List of the Financial Conduct Authority and to trading on the order book for retail bonds segment of the

Calmark's LDH test for assessment of COVID-19 enters the verification and validation phase of the CE marking process – analytical results are within the expected range

Calmark Sweden AB (publ) announces today that the development project for the Company's product COVID19-LDH now moves to verification and validation. This phase is one of last steps in the process, with an estimated duration of approximately five weeks. Thereafter, the product will move into production, and CE mark certification can take place.CE conformity marking and the development of medical devices follows a seven-step process, where the first three steps involve requirements capture and development. The product is then verified against the prescribed requirements and validated by

SOTKAMO SILVER AB: NEW NUMBER OF SHARES AND VOTES

Press release: Stockholm, February 18, 2021 16:30 CET Sotkamo Silver AB (“Sotkamo Silver”) has completed the conversion of SEK 15 million convertibles which was announced 10 February 2021. As a result of the conversion, the number of shares and votes in Sotkamo Silver has increased. Prior to the conversion, the number of shares and votes in Sotkamo Silver amounted to 179,977,732. New shares, 4,541,051, have been registered with the Swedish Companies Registration Office (Bolagsverket). Hence, as of today, February 18, 2021, the number of shares and votes in Sotkamo Silver amounts to

#21-66 Changes to Certain Loan Debenture at NGM

ISIN: SE0007100557 from Issuer Apikal Fastighetspartner AB has changed last day of trading to 2021-05-21.For more details, see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded

#21-65 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-64 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

New NMN supplement Elevant powers immunity and brings new levels of safety and transparency for consumers.

Elevant, a new brand with deep experience in cellular metabolism science, is bringing a clinically tested super nutrient with new levels of scientific rigor, quality, and safety to the cellular optimization market.New York, February 2021 – Elevant, an American health and wellness brand that develops cellular health solutions with leading scientists, has released an advanced dietary supplement containing a high purity form of NMN. Elevant is part of Seneque, an international biotechnology company established in Switzerland that is redefining healthspan and longevity. Elevant this week

Elkem ASA - Successful placement of senior unsecured NOK bonds

Oslo, 18 February 2021 Reference is made to notification dated 15 February 2021. Elkem ASA has today successfully issued NOK 1,250 million in new unsecured bonds. NOK 750 million has been issued with a tenor of 3 years and a coupon of 3 month Nibor + 1.00 % p.a. while NOK 500 million has been issued with a tenor of 5 years and a coupon of 3 month Nibor + 1.30 % p.a. The transaction was substantially oversubscribed. Settlement will take place on 26 February 2021. In connection with the bond issue, Elkem ASA has bought back NOK 419 million in ELK01 (ISIN NO0010838808). SEB and

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release February 18, 2021 at 4:40 p.m. Nokian Tyres has received an announcement from BlackRock, Inc. on February 18, 2021, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total number of Nokian Tyres shares owned by BlackRock, Inc. and its funds fell below level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on February 17, 2021. Total positions of BlackRock, Inc. and its funds subject to the notification: +----------------+----------+----------

Fazer initiates collaboration negotiations at Vantaa confectionery factory

Fazer is initiating collaboration negotiations concerning some of the personnel of the Vantaa confectionery plant due to financial and production-related grounds. Layoffs and temporary layoffs are planned due to changes in demand for Fazer’s confectionery products and to ensure profitability in the long run.Adjustment measures are required due to a change in demand patterns and to ensure product-specific profitability. The production capacity exceeds the demand, and the labour supply needs to be adjusted to reflect this situation. For example, demand for special praline products and other

Q-Free: Mandatory notification of trade

Snorre Kjesbu, Vice chair of the Board of directors of Q-Free ASA, has today acquired 45,000 shares in Q-Free ASA at an average price of NOK 5.655 per share. Following the transaction, Kjesbu owns 84,505 shares in Q-Free ASA. Ingeborg Molden Hegstad, member of the Board of directors of Q-Free ASA, has today acquired 17,850 shares in Q-Free ASA at an average price of NOK 5.60. The shares were acquired through Imsight AS, a company fully controlled by Hegstad. Following the transaction, Hegstad controls 42,450 shares in Q-Free ASA. This information is subject to disclosure requirements

J. Munch Holding ApS has increased its shareholding in DecideAct

DecideAct A/S [ACT] Company Announcement No. 4-2021:DecideAct A/S (the “Company”) hereby announces that J. Munch Holding ApS has notified the Company that J. Munch Holding ApS has increased its shareholding in the Company and now owns 12,04% of the share capital in the Company. Regarding the motivation for his involvement in DecideAct, Jens Munch states: “I consider DecidAct's product to be a highly scalable solution that also hits a global trend. Strategy execution is high on the agenda in all major companies, and the product is aimed directly at top management and decision-makers.”

Selvaag Bolig ASA: Transcript of Q4 2020 earnings presentation

Transcript of the Q4 2020 earnings presentation attached. The presentation was held on 17 February 2021 at 0830 CET. Further information from:Sverre Molvik, CEO, Selvaag Bolig ASATelephone: +47 40 10 05 85, e-mail: smo@selvaagbolig.no Kristoffer Gregersen, vice president communications and market, Selvaag Bolig ASATelephone: +47 95 77 55 93, e-mail: kgr@selvaagbolig.no   Selvaag Bolig ASA is a residential property developer controlling the entire value chain from acquisition of land to sale of homes. The company has several thousand homes under development at any given

Outokumpu – Transfer of the company’s own shares

Outokumpu OyjStock exchange releaseFebruary 18, 2021 at 4.15 pm EETOutokumpu – Transfer of the company’s own shares Based on the decision of the Board of Directors of Outokumpu Oyj, a total of 58,815 Outokumpu’s shares have been transferred for delivery to the personnel participating in the plan 2018-2020 of the Restricted Share Pool. The share rewards were announced on February 4, 2021. Trading code: OUT1VNumber of shares: 58,815Price/share: Gratuitous Outokumpu uses its treasury shares for the share rewards, which means that the total number of shares of the company does

IAR Systems strengthens functional safety offering with extended standards coverage

In addition to previous certification according to IEC 61508, ISO 26262, IEC 62304, EN 50128 and EN 50657, the certified edition of IAR Embedded Workbench for Arm now covers IEC 60730, ISO 13849, IEC 62061, IEC 61511 and ISO 25119Uppsala, Sweden—February 18, 2021—IAR Systems®, the future-proof supplier of software tools and services for embedded development, has updated the functional safety edition of the leading embedded development toolchain IAR Embedded Workbench® for Arm® with new functional safety certificates. The new certificates add IEC 60730 for Household Appliances, ISO 13849 and

Proposal by the Nomination Board for the Composition and Remuneration of the Board of Directors of Teleste Corporation

Teleste Oyj               Pörssitiedote 18.2.2021 klo 16:00 PROPOSAL BY THE NOMINATION BOARD FOR THE COMPOSITION AND REMUNERATION OF THE BOARD OF DIRECTORS OF TELESTE CORPORATION The General Meeting of Shareholders of Teleste Corporation (“Teleste”), held on April 22, 2020, decided, by proposal of Teleste’s Board of Directors, to set up a Nomination Board for the purpose of preparing proposals on the election and remuneration of the members of the Board of Directors to the Annual General Meeting and for ensuring that the Board of Directors and its members have sufficient competence

Interim Report April - December 2020

Continued growth during the third quarter.CEO’s comments The third quarter of 2020/21 was a stable quarter for EQL Pharma with slightly lower than average growth. Sales for the quarter, after a downward adjustment for non-recurring sales, amounted to SEK 23.4 million, an increase of 12%. Our goal is to become a leading player in niche generics in the Nordic region and eventually in Europe. To succeed in this, we need an agressive plan for rapid growth. The two principal components of this growth plan are geographical expansion of existing products and an increased number of new products.

Magnus Carlsen joining Team Kindred for the first Online World Corporate Chess Championship

Kindred Group is sending a team to the very first FIDE Online World Corporate Chess Campionship. The team of four includes Kindred employees as well as the World Champion and Unibet ambassador Magnus Carlsen.Kindred Group is signed up as one out of 288 teams registered to participate at the inaguaral edition of the FIDE Online World Corporate Chess Championship. The event brings together 1,467 players representing 78 different countries. Magnus Carlsen, who signed a two-year global sponsorship agreement with Unibet in 2020, will join three Kindred employees to form Team Kindred. The

ABAX partner up with Linkway to share data and provide GPS positioning

ABAX and Linkway today announced a new partnership which enables carriers who are using ABAX telematics to easily share positions with principals. The integration is a results of data sharing and will open new opportunities and services which increases the amount of features the customers will have on their solution.Enables to share positions Thanks to integration with ABAX, carriers who are using ABAX telematics can easily integrate with Linkway services and share positions with principals which means ABAX customers can share positions of vehicles so the customers business partners are

Read original

Year-end report 2020

Q4, October - December ·Net sales amounted to MSEK 721.2 (649.3). This corresponds to an increase of 11% for the period. ·The organic growth* during the fourth quarter was +1%. The currency impact in the quarter was -1% while the acquisitions of the product portfolios Proct[® ]from Leo Pharma and Pevaryl[® ]from Johnson & Johnson generated growth of 11%. ·EBIT (Operating Profit) amounted to MSEK -19.4 (8.2). ·Adjusted EBITDA* amounted to MSEK 164.8 (151.4) corresponding to growth of 9% excluding non-recurring items related to acquired product portfolios totalling

Diaverum becomes the largest independent renal care provider in Spain

Diaverum, a leading global renal care service provider, announces today the opening of 8 new clinics in Valencia, reflecting a significant growth journey in Spain that stems from superior medical outcomes, high quality of care and close cooperation with healthcare authorities and public hospitals.All the new Valencian clinics, built over the last six months, were inaugurated on the same day, on 17 February 2021. With these latest additions to its portfolio, Diaverum is now the market leader in private renal care provision in the region, operating a total of 20 clinics and treating

Financial Statement Full year 2020

Fourth Quarter 2020 ●  Incoming orders rose 7 % to SEK 897 million (836) ● Net sales rose 5 % to SEK 868 million (828) ● Operating profit rose 28 % to SEK 104 million (82) ● EBITA rose 26 % to SEK 107 million (85) ● Profit after tax rose 21 % to SEK 79 million (65) ● Earning per share were SEK 3,41 (2,82) January - December 2020 ●  Incoming order rose 2 % to SEK 3 368 million (3 303) ● Net sales amounted to SEK 3 283 million (3 299) ● Operating profit rose 10 % to SEK 408 million (371) ● EBITA rose 10 % to SEK 422 million (385) ● Profit after tax rose 10 %

There are no items matching the current filter
There are no more items matching the current filter
Back to top